by Bloomberg.com | Aug 27, 2024 | AlphaTack Intel
While lawmakers assail drug prices, Pfizer embraces its brand Company struggles with post-Covid lull, bridge to new drugs Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Using telehealth to sell drugs...
by Bloomberg.com | Aug 27, 2024 | AlphaTack Intel
Listings are ticking up but affordability remains an obstacle In June, New York prices rose fastest, followed by San Diego Home-price gains in the U.S. slowed in June as buyers pulled back from the market while listings started to climb. A national measure of prices...
by Bloomberg.com | Aug 27, 2024 | AlphaTack Intel
‘Discounts are starting to stabilize,’ CIO Puffer says PJT forecasts secondaries may hit record $145 billion in 2024 Smaller investors are beginning to test the secondary market for private equity holdings, providing greater stability to pricing, according to...
by Bloomberg.com | Aug 27, 2024 | AlphaTack Intel
PDD’s stock plunges 29% after a disappointing sales outlook Beijing has been struggling with slowing economic growth One of the last remaining bright spots for Chinese consumption is rapidly fading, as the nation’s economic malaise takes a toll on demand for even the...
by Bloomberg.com | Aug 27, 2024 | AlphaTack Intel
Strategy involves buying convertibles and selling shares short Gains on short position more than offset drop in bond price PDD Holdings Inc.’s record stock slide delivered gains to a popular hedge-fund strategy that seizes on the disconnect between the stock and...
by Bloomberg.com | Aug 26, 2024 | AlphaTack Intel
BYD should get preferential prices for SQM lithium carbonate Terms yet to be settled, BYD Executive Vice President Li says BYD Co. said the timing of its lithium project in Chile remains up in the air as the Chinese electric vehicle juggernaut continues to negotiate...
